自适应II/III期剂量优化设计中的不一致性调整
Adjustment for Inconsistency in Adaptive Phase 2/3 Designs with Dose Optimization
AI总结:
针对自适应II/III期设计中适应前后结果不一致的问题,提出在三种假设检验策略下纳入不一致性调整的统计分析方法,为后续研究奠定基础。
摘要:
自适应II/III期设计在当代肿瘤药物开发中具有巨大前景,尤其是当I期剂量探索的有限数据不足以确定最佳剂量时。然而,人们普遍担心适应前后结果不一致的问题。剂量选择的不完善进一步使问题复杂化。在本文中,我们明确地将对不一致性的关注纳入三种假设检验策略下的统计分析中。这项研究为这一较少探索的领域中的进一步研究铺平了道路。
英文摘要:
Adaptive Phase 2/3 designs hold great promise in contemporary oncology drug development, especially when limited data from Phase 1 dose-finding is insufficient for identifying an optimal dose. However, there is a general concern about inconsistent results before and after the adaptation. The imperfection in dose selection further complicates the issue. In this paper, we explicitly incorporate the concerns about inconsistency into the statistical analysis under three hypothesis testing strategies. This investigation paves the way for further research in a less explored area.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。